Clinical Evaluation of Laser Therapy Used as an Adjunct to Non-Surgical Treatment of Gum Disease
Primary Purpose
Periodontitis Chronic Generalized Moderate, Periodontitis Chronic Generalized Severe
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Laser Therapy
Non-surgical Scaling and Root Planing
Sponsored by
About this trial
This is an interventional treatment trial for Periodontitis Chronic Generalized Moderate focused on measuring Laser Therapy, Non-surgical periodontal therapy, Scaling and root planing
Eligibility Criteria
Inclusion Criteria:
- Age 18 years old or older (male or female)
- Healthy without systemic diseases that may adversely effect healing
- Not pregnant and no current plans to become pregnant
- No periodontal treatment in the previous 12 months
- No systemic antibiotic therapy in the previous 6 months
- At least two quadrants with periodontitis (ideally opposite side same jaw)
- Each quadrant must have two or more sites with probing pocket depths ≥ 5mm
- Each quadrant should include interproximal intrabony defect(s)
Exclusion criteria:
- Any systemic disease, medication, or habit known to adversely influence bone metabolism and/or wound healing:
- Poorly controlled diabetes (HbA1c > 7%)
- History of bisphosphonate medications
- History of radiation therapy affecting the proposed treatment site(s)
- History of immunosuppressive medications (e.g. corticosteroids)
- History of tobacco use (current or past tobacco use within the past 1 year)
- Immune compromise caused by disease, treatment or other condition
- Recent history of periodontal surgery (within the previous 2 years)
- Recent history of scaling and root planing (within the previous 12 months)
- Any condition that contraindicates periodontal therapy including surgery
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
SRP + Adjunctive Laser Therapy
SRP alone
Arm Description
Laser therapy used as an adjunct to scaling and root planing
Scaling and root planing used as conventional non-surgical periodontal therapy
Outcomes
Primary Outcome Measures
Probing Pocket Depth
This is a measure from base of pocket to gingival margin.
Sites That Bleed on Probing
Percentage of sites that bleed in response to probing. Bleeding observed within 30 seconds from pocket/sulcus following periodontal probe measurement.
Gingival Recession
Measure of gingival recession following treatment. This is a measure of the gingival margin from the cement-enamel junction.
Clinical Attachment Level
Periodontal clinical attachment level following treatment. This is a calculation (clinical attachment level = probing pocket depth + gingival recession).
Secondary Outcome Measures
Periodontal Microbiome
Assess changes in periodontal microbiome using DNA sequencing
Patient Reported Outcomes: VAS Questionnaire
Measure patient reported pain (0-100), comfort (0-100), sensitivity (0-100) and satisfaction (0-100) using VAS questionnaire, with lower values indicating better outcome for pain and sensitivity and higher values indicating better outcome for comfort and satisfaction.
Full Information
NCT ID
NCT04027686
First Posted
July 18, 2019
Last Updated
February 12, 2021
Sponsor
University of California, Los Angeles
Collaborators
Biolase Inc
1. Study Identification
Unique Protocol Identification Number
NCT04027686
Brief Title
Clinical Evaluation of Laser Therapy Used as an Adjunct to Non-Surgical Treatment of Gum Disease
Official Title
Clinical Evaluation of WaterLase (iPlus) Laser Therapy Used as an Adjunct to Non-Surgical Treatment of Chronic Periodontitis: A Randomized, Controlled, Split-Mouth Clinical Study
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Completed
Study Start Date
January 2017 (Actual)
Primary Completion Date
December 2019 (Actual)
Study Completion Date
December 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Los Angeles
Collaborators
Biolase Inc
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
The use of lasers to treat various problems in dentistry is growing as it has in medicine. One application is the use of lasers to treat periodontal disease. It has been suggested that the laser may reduce the need for surgical treatment by reducing pockets. The goal of this study is to evaluate the effectiveness of laser treatment for periodontal disease. Laser therapy will be used in addition to traditional non-surgical scaling and root planing (deep cleaning). The information obtained from this study will provide an objective assessment of adjunctive laser therapy compared to conventional periodontal therapy and will attempt to show the benefits, if any, lasers can provide in the treatment of chronic periodontal disease.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontitis Chronic Generalized Moderate, Periodontitis Chronic Generalized Severe
Keywords
Laser Therapy, Non-surgical periodontal therapy, Scaling and root planing
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized, Controlled, Split-mouth
Masking
None (Open Label)
Allocation
Randomized
Enrollment
23 (Actual)
8. Arms, Groups, and Interventions
Arm Title
SRP + Adjunctive Laser Therapy
Arm Type
Experimental
Arm Description
Laser therapy used as an adjunct to scaling and root planing
Arm Title
SRP alone
Arm Type
Active Comparator
Arm Description
Scaling and root planing used as conventional non-surgical periodontal therapy
Intervention Type
Device
Intervention Name(s)
Laser Therapy
Intervention Description
Adjunctive application of laser therapy in the periodontal pocket
Intervention Type
Procedure
Intervention Name(s)
Non-surgical Scaling and Root Planing
Intervention Description
Scaling to remove calculus deposits and root planing to smooth root surfaces
Primary Outcome Measure Information:
Title
Probing Pocket Depth
Description
This is a measure from base of pocket to gingival margin.
Time Frame
12 months
Title
Sites That Bleed on Probing
Description
Percentage of sites that bleed in response to probing. Bleeding observed within 30 seconds from pocket/sulcus following periodontal probe measurement.
Time Frame
12 months
Title
Gingival Recession
Description
Measure of gingival recession following treatment. This is a measure of the gingival margin from the cement-enamel junction.
Time Frame
12 months
Title
Clinical Attachment Level
Description
Periodontal clinical attachment level following treatment. This is a calculation (clinical attachment level = probing pocket depth + gingival recession).
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Periodontal Microbiome
Description
Assess changes in periodontal microbiome using DNA sequencing
Time Frame
12 months
Title
Patient Reported Outcomes: VAS Questionnaire
Description
Measure patient reported pain (0-100), comfort (0-100), sensitivity (0-100) and satisfaction (0-100) using VAS questionnaire, with lower values indicating better outcome for pain and sensitivity and higher values indicating better outcome for comfort and satisfaction.
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age 18 years old or older (male or female)
Healthy without systemic diseases that may adversely effect healing
Not pregnant and no current plans to become pregnant
No periodontal treatment in the previous 12 months
No systemic antibiotic therapy in the previous 6 months
At least two quadrants with periodontitis (ideally opposite side same jaw)
Each quadrant must have two or more sites with probing pocket depths ≥ 5mm
Each quadrant should include interproximal intrabony defect(s)
Exclusion criteria:
Any systemic disease, medication, or habit known to adversely influence bone metabolism and/or wound healing:
Poorly controlled diabetes (HbA1c > 7%)
History of bisphosphonate medications
History of radiation therapy affecting the proposed treatment site(s)
History of immunosuppressive medications (e.g. corticosteroids)
History of tobacco use (current or past tobacco use within the past 1 year)
Immune compromise caused by disease, treatment or other condition
Recent history of periodontal surgery (within the previous 2 years)
Recent history of scaling and root planing (within the previous 12 months)
Any condition that contraindicates periodontal therapy including surgery
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Perry R Klokkevold, DDS, MS
Organizational Affiliation
UCLA School of Dentistry, Section of Periodontics
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Clinical Evaluation of Laser Therapy Used as an Adjunct to Non-Surgical Treatment of Gum Disease
We'll reach out to this number within 24 hrs